secwatch / observer
8-K filed February 5, 2024, 6:59 PM ET CIK 0001850502
other material confidence high sentiment neutral materiality 0.45

Enphys shareholders approve extension to June 8, 2024; ~3.94M shares redeemed

Enphys Acquisition Corp.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Enphys Acquisition Corp.: Amendment to amended and restated memorandum and articles of association to extend business combination deadline from February 8, 2024 to June 8, 2024 (effective 2024-02-02).

Change
charter amendment
Effective
2024-02-02
Exact text from the filing
On February 2, 2024, Enphys Acquisition Corp. (the “Company”) held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) to vote on the proposal described under Item 5.07 of this Current Report on Form 8-K. At the Extraordinary General Meeting, the Company’s shareholders approved an amendment to the Company’s amended and restated memorandum and articles of association (the “Extension Amendment”) to extend the date by which the Company must consummate a business combination from February 8, 2024 to June 8, 2024 (the “Extended Date”) (the “Extension Amendment Proposal”).
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Enphys Acquisition Corp. shareholders approved Extension Amendment to extend the date by which the Company must consummate a business combination from February 8, 2024 to June 8, 2024 at the 2024-02-02 meeting.

Proposal
charter amendment
Outcome
passed
Meeting
2024-02-02
Exact text from the filing
The voting results for the Extension Amendment Proposal was as follows: The Extension Amendment Proposal For Against Abstain 13,413,126 400,003 78,125
View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR
accession 0001140361-24-005649
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.